Based on kind, the Neuropathic Pain Market is divided into proximal neuropathy, autonomic neuropathy, focal neuropathy, and painful diabetic peripheral neuropathy (PDPN). Due to a rise in widespread knowledge of peripheral neuropathy, the peripheral sector accounted for the majority of the market expansion. According to the National Center for Biotechnology Information, the prevalence of peripheral diabetic neuropathy in people varies from 6% to 51%, depending on a number of factors including age, type of diabetes, glucose control, and length of diabetes.
Based on indication, diabetic neuropathy, spinal stenosis, and chemotherapy-induced peripheral neuropathy, the neuropathic pain market is segmented. The Neuropathic Pain Market was led by the diabetic neuropathy category. The key variables influencing the diabetic neuropathy segment include the growth in obesity rates brought on by poor diets and sedentary lifestyles, as well as improved knowledge of diabetes diagnosis and treatment.
